Avantor (NYSE: AVTR ) is a global leader of critical products and services with world-class distribution positioned to grow mid-single digits over the long term. Industry headwinds from destocking, the IRA bill, and normalization of growth have weighed on the stock price, drivingAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses m ...

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings ...

RADNOR, Pa., Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m. Eastern Standard Time.To hear a live audio webcast of the session, visit Events & Presentations in the ...

Avantor's new Bridgewater Innovation Center spans 60,000 square feet, doubling its previous laboratory and pilot plant capacity. Purpose-designed for collaborative work, the center houses spaces for upstream and downstream process development, dedicated analytical testing labs, and a viral vector laboratory. An expanded pilot plant supports scale-up simulations, enabling rapid customization across the entire bioprocessing workflow. "Our new Bridgewater Innovation Center is twice the size of our previous fac ...

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an empha ...

RADNOR, Pa., Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D., as a director with an initial term expiring at Avantor's 2025 Annual Meeting of Stockholders. The appointment of Dame Louise as an independent director fills a vacant board seat.Dame Louise brings a wealth of lead ...

(Vavantor Q3 2024 Earnings EARNINGS PRESENTATION October 25, 2024 AVTR LISTED NYSE Disclaimer This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking ...

Avantor, Inc. (AVTR) reported third-quarter 2024 adjusted earnings per share (EPS) of 26 cents, up by a penny from the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate by 4%. GAAP EPS for the quarter was 8 cents, down 50% year over year. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. AVTR Revenue Details Revenues grossed $1.71 billion in the reported quarter, down 0.3% year over year. The metric missed the Zacks Consensus Estimate by 0.6%. Per management, the ...

Avantor Inc. (NYSE:AVTR) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Daniel Leonard - UBS Conor McNamara - RBC Capital Markets Daniel Arias - Sti ...

Core Insights - Avantor, Inc. reported $1.71 billion in revenue for Q3 2024, reflecting a year-over-year decline of 0.3% [1] - The company's EPS for the same period was $0.26, compared to $0.25 a year ago, indicating a slight improvement [1] - Revenue fell short of the Zacks Consensus Estimate of $1.72 billion, resulting in a surprise of -0.57% [1] - The EPS exceeded the consensus estimate of $0.25, delivering a surprise of +4.00% [1] Revenue Breakdown - Bioscience Production revenue was $542.90 million, below the average estimate of $550.65 million from four analysts [2] - Laboratory Solutions revenue matched the estimate at $1.17 billion [2] Operating Income Analysis - Adjusted Operating Income for Laboratory Solutions was $151.50 million, compared to the average estimate of $155.83 million [2] - Adjusted Operating Income for Corporate was -$14.80 million, better than the average estimate of -$17.46 million [2] - Adjusted Operating Income for Bioscience Production was $138.10 million, below the average estimate of $143.89 million [2] Stock Performance - Avantor's shares have declined by 10.7% over the past month, while the Zacks S&P 500 composite increased by 1.4% [2] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [2]